← Back to Search
Stereoselectivities Of Enantiomers Of Huperzine A In Protection Against β-amyloid25–35-induced Injury In PC12 And NG108-15 Cells And Cholinesterase Inhibition In Mice
H. Zhang, Y. Liang, X. Tang, X. He, D. Bai
Published 2002 · Biology, Medicine
Download PDFAnalyze on Scholarcy
Recently, the potent cholinesterase inhibitor (-)-huperzine A (HupA) was demonstrated to protect neuronal and glial cells against the cytotoxicity of beta-amyloid (Abeta). Since the unnatural (+)-HupA is a much less potent inhibitor, it was of interest to examine the stereoselectivity of cellular protection by the two isomers. In the present study, effects of (+)- and (-)-HupA on Abeta(25-35)-induced injury were compared in PC12 and NG108-15 neuroblastoma cell lines. Following a 24 h exposure to 1 microM Abeta(25-35), cell survival was markedly reduced, but preincubation with (+)-HupA or (-)-HupA (0.1-10 microM) enhanced survival significantly. The potency of (-)-HupA and (+)-HupA in protecting against Abeta toxicity was similar. This result contrasted with the stereoselectivity of cholinesterase inhibition in vitro and in vivo, in which (-)-HupA is about 50-fold more potent than (+)-HupA. It is concluded that the neuroprotective properties of HupA enantiomers have no relation to anti-cholinesterase activity.
This paper references
Alzheimer's disease--from molecular biology to therapy.
R. Mayer (1993)
Huperzine B, a novel acetylcholinesterase inhibitor, attenuates hydrogen peroxide induced injury in PC12 cells
H. Zhang (2000)
Cell biology of the amyloid beta-protein precursor and the mechanism of Alzheimer's disease.
D. Selkoe (1994)
Stable Complexes Involving Acetylcholinesterase and Amyloid-β Peptide Change the Biochemical Properties of the Enzyme and Increase the Neurotoxicity of Alzheimer’s Fibrils
A. Álvarez (1998)
Comparison of the effects of natural and synthetic huperzine-A on rat brain cholinergic function in vitro and in vivo.
X. Tang (1994)
Huperzine A and tacrine attenuate β‐amyloid peptide‐induced oxidative injury
X. Q. Xiao (2000)
Synthesis, chiral chromatographic separation, and biological activities of the enantiomers of 10,10-dimethylhuperzine A.
V. Rajendran (2000)
Cholinesterase Inhibitors: An Overview of their Mechanisms of Action
A. Enz (1997)
beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity
M. Mattson (1992)
Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides.
B. Yankner (1990)
Similar potency of the enantiomers of huperzine A in inhibition of [3H]dizocilpine (MK-801) binding in rat cerebral cortex
Y. Zhang (2000)
Huperzine A, a novel promising acetylcholinesterase inhibitor
D. Cheng (1996)
The cholinergic system in Alzheimer's disease
Péter Kása (1997)
A new and rapid colorimetric determination of acetylcholinesterase activity.
G. Ellman (1961)
Structure of acetylcholinesterase complexed with the nootropic alkaloid, (–)-huperzine A
M. L. Raves (1997)
Potencies and stereoselectivities of enantiomers of huperzine A for inhibition of rat cortical acetylcholinesterase.
M. Mckinney (1991)
Acetylcholinesterase is a senile plaque component that promotes assembly of amyloid beta-peptide into Alzheimer's filaments.
N. Inestrosa (1996)
HUPERZINE A : A NOVEL ACETYLCHOLINESTERASE INHIBITOR
X. Tang (1999)
Tacrine and donepezil attenuate the neurotoxic effect of Aβ(25‐35) in rat PC12 cells
A. Svensson (1998)
Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill.
M. Hansen (1989)
This paper is referenced by
Huperzine A attenuates cognitive deficits and brain injury in neonatal rats after hypoxia–ischemia
L. Wang (2002)
Total Synthesis of Huperzine Q.
S. Tanimura (2017)
Non-cholinergic Effects of Huperzine A: Beyond Inhibition of Acetylcholinesterase
H. Zhang (2007)
Recent pharmacological studies on natural products in China.
X. Zhu (2004)
Molecular dynamics simulations of interaction between protein-tyrosine phosphatase 1B and a bidentate inhibitor
G. Liu (2006)
The effects of Liuwei Dihuang decoction on the gene expression in the hippocampus of senescence-accelerated mouse.
Xiao-rui Cheng (2007)
Potential therapeutic targets of huperzine A for Alzheimer's disease and vascular dementia.
H. Zhang (2008)
Involvement of Intracellular and Mitochondrial Aβ in the Ameliorative Effects of Huperzine A against Oligomeric Aβ42-Induced Injury in Primary Rat Neurons
Y. Lei (2015)
Is It Reliable to Use Common Molecular Docking Methods for Comparing the Binding Affinities of Enantiomer Pairs for Their Protein Target?
D. Ramírez (2016)
The Lycopodium alkaloids.
Xiaoqiang Ma (2004)
Huperzine a provides neuroprotection against several cell death inducers usingin vitro model systems of motor neuron cell death
R. Hemendinger (2009)
Strategies Developed for the Treatment of Alzheimer ’ s Disease . Reversible and Pseudo-Irreversible Inhibitors of Acetylcholinesterase : Structure-Activity Relationships and Drug Design
TrkA pathway activation induced by amyloid-beta (Abeta)
A. Bulbarelli (2009)
Neuroprotection and Enhancement of Learning and Memory by BF-7
Dae Kyong Kim (2005)
The pharmacology and therapeutic potential of (−)-huperzine A
Maung Kyaw Moe Tun (2012)
Effects of Ginsenoside Rg1 on the Expression of Toll-Like Receptor 3, 4 and Their Signalling Transduction Factors in the NG108-15 Murine Neuroglial Cell Line
Bao-sheng Zhao (2014)
[+]-Huperzine A Protects Against Soman Toxicity in Guinea Pigs
Y. Wang (2011)
Huperzine A as a neuroprotective and antiepileptic drug: a review of preclinical research
U. Damar (2016)
Behavioural effects of novel multitarget anticholinesterasic derivatives in Alzheimer's disease.
Lydia Giménez-Llort (2017)
Research Strategies Developed for the Treatment of Alzheimer’s Disease. Reversible and Pseudo-Irreversible Inhibitors of Acetylcholinesterase: Structure-Activity Relationships and Drug Design
M. Alcolea-Palafox (2014)
Treating senile dementia with traditional Chinese medicine
H. Yan (2007)
Lycopodium Alkaloids: Pharmacology
E. Olafsdottir (2013)
Progress in studies of huperzine A, a natural cholinesterase inhibitor from Chinese herbal medicine
R. Wang (2006)
Huperzine A attenuates the neurotoxic effect of staurosporine in primary rat cortical neurons
H. Zhang (2003)
Acetylcholinesterase as a Pharmacological Target in Cancer Research
S. Park (2010)
Huperzine A: Is it an Effective Disease-Modifying Drug for Alzheimer’s Disease?
Z. Qian (2014)
Actions of Bioactive Phytochemicals in Cell Function and Alzheimer’s Disease Pathology
Richard Hartman (2009)
The psychopharmacology of huperzine A: an alkaloid with cognitive enhancing and neuroprotective properties of interest in the treatment of Alzheimer's disease
Andrea Zangara (2003)
Natural Compounds (Small Molecules) as Potential and Real Drugs of Alzheimer's Disease
L. Cahlíková (2014)
Huperzine A: A promising anticonvulsant, disease modifying, and memory enhancing treatment option in Alzheimer's disease.
Ugur Damar (2017)
β‐amyloid (25–35) enhances lipid metabolism and protein ubiquitination in cultured neurons
E. Cazzaniga (2007)
Age-related expression of calcium/calmodulin-dependent protein kinase II A in the hippocampus and cerebral cortex of senescence accelerated mouse prone/8 mice is modulated by anti–Alzheimer's disease drugs
G. Zhang (2009)See more